Carmella L. Stephens, counsel in the New York office, has substantial experience in a wide variety of intellectual property matters, with a particular emphasis in the biotechnology and pharmaceutical industries. In particular, Dr. Stephens has prepared and prosecuted many applications involving gene therapy, RNA based therapeutics, bioassays, immunobiology, signal transduction and genomics, to name a few. Dr. Stephens has also counseled clients on legal issues relating to biotechnology and pharmaceutical patents, including patent enforcement, validity and infringement, licensing, and business development.
Dr. Stephens has been an instructor for the Practising Law Institute's yearly Conference on Advanced Claim Drafting & Amendment Writing in Biotechnology Practice. She is involved in the New York Biotechnology Association (NYBA) and the Association of University Technology Managers, Inc. (AUTM).
Dr. Stephens’ thesis research was conducted at Cold Spring Harbor Laboratory and concentrated on adenovirus E1A proteins and their role in cell proliferation. After receiving her Ph.D., she completed a post-doctoral fellowship at Memorial Sloan-Kettering Institute where her research focused on transforming growth factor-ß mediated signal transduction.